Shares of Express Scripts Holding (NASDAQ:ESRX) have received a consensus recommendation of “Hold” from the twenty-four ratings firms that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $81.45.
ESRX has been the subject of a number of recent research reports. Deutsche Bank initiated coverage on shares of Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price target for the company. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, December 4th. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Sanford C. Bernstein upgraded shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, December 14th.
Express Scripts (NASDAQ ESRX) traded down $0.77 during trading hours on Friday, hitting $76.23. 3,629,541 shares of the stock traded hands, compared to its average volume of 5,192,566. The company has a market cap of $43,220.00, a price-to-earnings ratio of 9.92, a P/E/G ratio of 0.96 and a beta of 0.94. The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. Express Scripts has a 12 month low of $55.80 and a 12 month high of $85.07.
Express Scripts declared that its board has initiated a share buyback program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.
In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Everett Neville sold 4,895 shares of Express Scripts stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The disclosure for this sale can be found here. Insiders have sold a total of 21,896 shares of company stock worth $1,617,903 over the last ninety days. Insiders own 0.68% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of ESRX. Raymond James Financial Services Advisors Inc. boosted its holdings in Express Scripts by 15.2% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 252,263 shares of the company’s stock worth $15,973,000 after acquiring an additional 33,269 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Express Scripts by 12.5% in the 3rd quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after buying an additional 3,940 shares during the last quarter. Boston Partners boosted its holdings in shares of Express Scripts by 8.0% in the 3rd quarter. Boston Partners now owns 837,454 shares of the company’s stock worth $53,028,000 after buying an additional 62,359 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its holdings in shares of Express Scripts by 4.1% in the 3rd quarter. Candriam Luxembourg S.C.A. now owns 261,777 shares of the company’s stock worth $16,576,000 after buying an additional 10,418 shares during the last quarter. Finally, Global X MANAGEMENT CO LLC boosted its holdings in shares of Express Scripts by 11.3% in the 3rd quarter. Global X MANAGEMENT CO LLC now owns 12,102 shares of the company’s stock worth $766,000 after buying an additional 1,227 shares during the last quarter. 89.08% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://sportsperspectives.com/2018/03/14/express-scripts-holding-esrx-receives-81-35-consensus-price-target-from-brokerages.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.